Division of Gastrointestinal Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Department of Surgery, Inha University Hospital, Inha University College of Medicine, Incheon, Korea.
J Gastric Cancer. 2024 Jul;24(3):341-352. doi: 10.5230/jgc.2024.24.e29.
Textbook outcome is a comprehensive measure used to assess surgical quality and is increasingly being recognized as a valuable evaluation tool. Delta-shaped anastomosis (DA), an intracorporeal gastroduodenostomy, is a viable option for minimally invasive distal gastrectomy in patients with gastric cancer. This study aims to evaluate the surgical outcomes and calculate the textbook outcome of DA.
In this retrospective study, the records of 4,902 patients who underwent minimally invasive distal gastrectomy for DA between 2009 and 2020 were reviewed. The data were categorized into three phases to analyze the trends over time. Surgical outcomes, including the operation time, length of post-operative hospital stay, and complication rates, were assessed, and the textbook outcome was calculated.
Among 4,505 patients, the textbook outcome is achieved in 3,736 (82.9%). Post-operative complications affect the textbook outcome the most significantly (91.9%). The highest textbook outcome is achieved in phase 2 (85.0%), which surpasses the rates of in phase 1 (81.7%) and phase 3 (82.3%). The post-operative complication rate within 30 d after surgery is 8.7%, and the rate of major complications exceeding the Clavien-Dindo classification grade 3 is 2.4%.
Based on the outcomes of a large dataset, DA can be considered safe and feasible for gastric cancer.
教科书结果是一种综合的衡量标准,用于评估手术质量,并且越来越被认为是一种有价值的评估工具。Delta 形吻合术(DA)是一种腔内胃十二指肠吻合术,是一种可行的微创远端胃癌根治术选择。本研究旨在评估 DA 的手术结果并计算教科书结果。
本回顾性研究分析了 2009 年至 2020 年间接受微创远端胃癌 DA 的 4902 例患者的记录。将数据分为三个阶段,以分析随时间的变化趋势。评估了手术结果,包括手术时间、术后住院时间和并发症发生率,并计算了教科书结果。
在 4505 例患者中,3736 例(82.9%)达到了教科书结果。术后并发症对教科书结果的影响最大(91.9%)。第二阶段(85.0%)的教科书结果最高,超过了第一阶段(81.7%)和第三阶段(82.3%)的结果。术后 30 天内的并发症发生率为 8.7%,Clavien-Dindo 分级 3 以上的严重并发症发生率为 2.4%。
基于大型数据集的结果,DA 可被认为是安全可行的胃癌治疗方法。